Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Black Diamond Therapeutics (BDTX) Shares Outstanding (2018 - 2025)

Black Diamond Therapeutics' Shares Outstanding history spans 6 years, with the latest figure at $57.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.87% year-over-year to $57.1 million; the TTM value through Dec 2025 reached $57.1 million, up 0.87%, while the annual FY2025 figure was $57.1 million, 0.87% up from the prior year.
  • Shares Outstanding reached $57.1 million in Q4 2025 per BDTX's latest filing, roughly flat from $56.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $57.1 million in Q4 2025 to a low of $36.1 million in Q1 2021.
  • Average Shares Outstanding over 3 years is $50.8 million, with a median of $56.5 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: increased 0.66% in 2021, then increased 7.9% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $36.2 million in 2021, then skyrocketed by 56.35% to $56.6 million in 2024, then rose by 0.87% to $57.1 million in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Shares Outstanding are $57.1 million (Q4 2025), $56.9 million (Q3 2025), and $56.9 million (Q2 2025).